For this, it is key to have a team by your side that knows the nuances of regulations and know what it entails
Patients with obesity-related complications frequently have stronger medical necessity documentation because weight loss may improve overall health outcomes
This review summarizes recent advances in GLP-1R-targeted nanoplatforms, including lipid nanoparticles, polymeric carriers, inorganic nanoparticles, and biomimetic scaffolds that improve peptide stability, prolong circulation half-life, and enable selective tissue targeting
So, the obvious and important question is: Why not
21 Given this critical findings, The ADA advises using GLP-1 RAs to treat type 2 diabetes in adults with MASH, citing histological benefits demonstrated in the mentioned phase 2 randomized controlled trials